© 2020 MJH Life Sciences and Cancer Network. All rights reserved.
Author | Jean-Bernard Durand, MD
Articles
Protecting Breast Cancer Patients From Cardiac Adverse Effects of Treatment With Anthracyclines and HER2-Targeted Therapies
March 22, 2018
ByJean-Bernard Durand, MDDuring the 2018 Miami Breast Cancer Conference, cardiologist Dr. Jean-Bernard Durand discussed protecting patients who are being treated with anthracyclines and HER2-targeted therapies from serious cardiac adverse events.